What is the best treatment for women with 20-week sized uterine fibroids who desire fertility?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Treatment for Women with 20-Week Fibroids Desiring Fertility

Laparoscopic or open myomectomy is the most appropriate first-line treatment for women with 20-week sized uterine fibroids who desire fertility. 1

Treatment Options Based on Evidence

First-Line Treatment: Myomectomy

  • Laparoscopic or open myomectomy is recommended as the primary treatment for women with large fibroids who desire fertility 1
  • Open myomectomy is preferred over laparoscopic approaches for very large uteri (such as 20-week size) or multiple fibroids 1
  • Both approaches demonstrate similar pregnancy and live birth rates in randomized controlled trials 1
  • The combined miscarriage rate after myomectomy (14%) is comparable to the general population 1
  • Laparoscopic myomectomy offers advantages of shorter hospital stays, less postoperative pain, and faster recovery compared to open myomectomy 1, 2

Fibroid Location Considerations

  • Submucosal fibroids have the most detrimental effect on fertility with the lowest pregnancy rates (10%) and implantation rates (4.3%) 3
  • For submucosal fibroids, hysteroscopic myomectomy should be performed if present along with the larger fibroids 3
  • Intramural fibroids significantly reduce pregnancy rates (16.4%) compared to women without fibroids 3
  • Subserosal fibroids have minimal impact on fertility but may contribute to bulk symptoms in large 20-week sized uteri 3

Alternative Options

Medical Management

  • Medical management can be considered as a temporary measure before surgery 1
  • Ulipristal acetate has shown a 41% reduction in fibroid volume with pregnancy rates similar to controls without fibroids 1, 3
  • Most medical therapies (like GnRH agonists/antagonists) suppress fertility and are primarily used for short-term fibroid size reduction before surgery 1

Uterine Artery Embolization (UAE)

  • UAE is generally not recommended as first-line treatment for women desiring fertility 1
  • Studies show increased risks of miscarriage (35%), cesarean sections (66%), and postpartum hemorrhage (13.9%) after UAE compared to myomectomy 1
  • Current evidence suggests myomectomy is superior to UAE for women planning future pregnancy 1

MR-Guided Focused Ultrasound (MRgFUS)

  • Evidence for MRgFUS for fertility enhancement is limited to case reports 1
  • A randomized controlled trial investigating MRgFUS for fertility was terminated due to lack of enrollment 1

Treatment Algorithm

  1. Confirm diagnosis and fibroid characteristics with imaging (MRI preferred for precise mapping)
  2. Rule out other causes of infertility with complete infertility workup 1
  3. Primary treatment: Laparoscopic or open myomectomy based on:
    • For 20-week sized fibroids: Open myomectomy is typically preferred 1
    • For multiple fibroids: Open approach offers better access 1
  4. Consider pre-surgical medical therapy to reduce fibroid size and surgical complexity:
    • GnRH agonists/antagonists for 2-3 months before surgery 1
  5. Post-myomectomy recommendations:
    • Wait at least 2-3 months before attempting pregnancy to allow uterine healing 4
    • Monitor for return of normal menstrual function 4

Important Caveats

  • Hysterectomy is never appropriate for women desiring fertility as it causes permanent and irreversible infertility 1
  • Endometrial ablation is contraindicated in women desiring pregnancy due to high risk of pregnancy complications 1, 3
  • For very large fibroids (20-week size), the surgical approach requires expertise in complex myomectomy techniques 2
  • Pregnancy rates after myomectomy range from 54-59.5% in women with no other apparent cause of infertility 3
  • The risk of fibroid recurrence after myomectomy is approximately 15-30% within 5 years 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Endoscopic management of uterine fibroids.

Best practice & research. Clinical obstetrics & gynaecology, 2008

Guideline

Management of Uterine Fibroids in Infertile Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Post-Operative Care for Laparoscopic Myomectomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Myomectomy: technique and current indications.

Minerva ginecologica, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.